SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Braithwaite RS, Col NF, Wong JB 2003 Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51: 364370.
  • 2
    Wenger NK 2003 Coronary heart disease: The female heart is vulnerable. Prog Cardiovasc Dis 46: 199229.
  • 3
    Soldo BJ, Agree EM 1988 America's elderly. Popul Bull 43: 153.
  • 4
    American Heart Association Heart Disease and Stroke Statistics—2004 Update. American Heart Association, Dallas, TX, USA, 2003.
  • 5
    Tankó LB, Bagger YZ, Christiansen C 2003 Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73: 1520.
  • 6
    Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE 2004 Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15: 389395.
  • 7
    Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV 1998 Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62: 209213.
  • 8
    Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW 2001 Bone loss and the progression of abdominal aortic calcification over a 25-year period: The Framingham Heart Study. Calcif Tissue Int 68: 271276.
  • 9
    Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC 2000 Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study. Arterioscler Thromb Vasc Biol 20: 19261931.
  • 10
    Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS 1998 Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31: 126133.
  • 11
    Iribarren C, Sidney S, Sternfeld B, Browner WS 2000 Calcification of the aortic arch: Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 283: 28102815.
  • 12
    Laroche M, Moulinier L, Leger P, Lefebvre D, Mazieres B, Boccalon H 2003 Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. Clin Exp Rheumatol 21: 103106.
  • 13
    Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B 1994 Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13: 611614.
  • 14
    von der Recke P, Hansen MA, Hassager C 1999 The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106: 273278.
  • 15
    Samelson EJ, Kiel DP, Broe KE, Zhang Y, Cupples LA, Hannan MT, Wilson PWF, Levy D, William SA, Vaccarino V 2004 Metacarpal cortical area and risk of coronary heart disease. The Framingham Study. Am J Epidemiol 159: 589595.
  • 16
    Browner WS, Seeley DG, Vogt TM, Cummings SR 1991 Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 338: 355358.
  • 17
    Trivedi DP, Khaw KT 2001 Bone mineral density at the hip predicts mortality in elderly men. Osteoporos Int 12: 259265.
  • 18
    Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR 1999 Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282: 637645.
  • 19
    Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD, MORE Investigators (Multiple Outcomes of Raloxifene Evaluation) 2002 Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287: 847857.
  • 20
    Mosca LM, Barrett-Connor E, Wenger N, Collins P, Grady D, Kornitzer M, Moscarelli E, Paul S, Wright T, Helterbrand JD, Anderson PW 2001 Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol 88: 392395.
  • 21
    Kanis JA, Johnell O, Black DM, Downs RW Jr, Sarkar S, Fuerst T, Secrest RJ, Pavo I 2003 Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: A reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 33: 293300.
  • 22
    Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R 1998 Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8: 468489.
  • 23
    Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9: 11371141.
  • 24
    Genant HK, Wu CY, van Kuijk C, Nevitt MC 1993 Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8: 11371148.
  • 25
    Grant RW, Meigs JB 2004 Should the insulin resistance syndrome be treated in the elderly? Drugs Aging 21: 141151.
  • 26
    Ensrud KE, Thompson DE, Cauley JA, Nevitt MC, Kado DM, Hochberg MC, Santora AC II, Black DM 2000 Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48: 241249.
  • 27
    McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR 2004 Osteoporosis and cardiovascular disease: Brittle bones and boned arteries, is there a link? Endocrine 23: 110.
  • 28
    Demer LL, Tintut Y 2003 Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 23: 17391743.
  • 29
    Abedin M, Tintut Y, Demer LL 2004 Vascular calcification: Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 11611170.
  • 30
    Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339: 733738.
  • 31
    Goderie-Plomp HW, van der Klift M, de Ronde W, Hofman A, de Jong FH, Pols HA 2004 Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: The Rotterdam Study. J Clin Endocrinol Metab 89: 32613269.
  • 32
    Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI 2003 Postmenopausal Estrogen/Progestin Intervention Trial Association of endogenous sex hormones and insulin resistance among postmenopausal women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 88: 16461652.
  • 33
    Goodman-Gruen D, Barrett-Connor E 2000 Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23: 912918.
  • 34
    Tankó LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C, Larsen PJ 2004 Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: Implications for atherogenesis. Circulation 110: 22462252.
  • 35
    Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET 1998 Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21: 12581265.
  • 36
    Knopp RH 2002 Risk factors for coronary artery disease in women. Am J Cardiol 89: 28E34E.
  • 37
    Whitcomb BW, Bruder JM, Bauer RL, Mahaney MC, Tracy RP, Kammerer CM, Mitchell BD 2004 C-reactive protein levels are associated with decreased bone mineral density in Mexican Americans. J Bone Miner Res 19: S289.
  • 38
    Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K 2005 Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 97: 329333.
  • 39
    van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG 2004 Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350: 20332041.
  • 40
    Golledge J, McCann M, Mangan S, Lam A, Karan M 2004 Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 35: 16361641.
  • 41
    Mantovani A, Sozzani S, Introna M 1997 Endothelial activation by cytokines. Ann N Y Acad Sci 832: 93116.
  • 42
    Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC 1993 Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J Clin Endocrinol Metab 77: 16481653.
  • 43
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680687.
  • 44
    Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL 2001 Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104: 448454.
  • 45
    Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, Ralston SH 2001 Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142: 760766.